Pure IDO play (almost, they have an ebola program) NLNK - which I nearly put in my charity portfolio - up 18% on no company specific news (don't think they're at JPM today). Coattailing on INCY? They have two P1 combo trials with PD-1 inhibitors. Regards, RockRat